Brief: Effector Therapeutics Announces $8.7 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
June 7 (Reuters) - eFFECTOR Therapeutics Inc EFTR.O :
* EFFECTOR THERAPEUTICS ANNOUNCES $8.7 MILLION REGISTERED
DIRECT
OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
* EFFECTOR THERAPEUTICS-DEFINITIVE AGREEMENT WITH SINGLE
INSTITUTIONAL INVESTOR FOR PURCHASE, SALE OF AGGREGATE OF 7.76
MILLION SHARES AT $1.125/SHARE
Source text for Eikon: ID:nGNX3bvkZL
Further company coverage: EFTR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Effector Therapeutics
See all newsBrief: Effector Therapeutics Expects To Incur One-Time Charges And Cash Expenditures
Brief: Effector Therapeutics Announces It Will Wind Down Operations
Brief: Effector Therapeutics To Collaborate With The Dana-Farber Cancer Institute
eFFECTOR Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: eFFECTOR Therapeutics Enters Into An At The Market Offering Agreement With H.C. Wainwright